EUVIMEDEUVIMED entdecken
Open Access

Generating Real‐World Evidence From the Excellence Network in Rheumatology

Timothy Beukelman iD, Amy Mudano, Patrick Stewart, Shilpa Venkatachalam, Fenglong Xie, Michael George, Howard Busch, Priya Reddy, Kenneth G Saag, Yujie Su, Jeffrey R Curtis

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Timothy Beukelman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Advancing Science, Technology, Education, and Research (FASTER), Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Rheumatology, Electronic Health Records. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The Excellence Network in RheumatoloGY (ENRGY) was founded in 2021 and encompasses data from more than 700 private practice rheumatology providers throughout the United States, forming a practice‐based research network (PBRN).

Methods

Electronic health record (EHR) data from participating practices are aggregated, including structured data (e.g., clinical assessments) and unstructured data from two different EHR platforms. Targeted data quality efforts ensure capture of high‐quality clinical data and reduce missingness. ENRGY network membership also provides participating sites access to technology services that enhance patient care. Centralized ethics approval and pre‐existing legal agreements along with electronic tools to curate data and contact eligible study participants improves efficiency of multi‐center prospective studies.

Results

The ENRGY data warehouse includes linked administrative claims data for commercial and government‐provided insurance (31% of patients linked to commercial claims) and patient‐generated health data from both in‐office and out‐of‐office settings via a smartphone app as well as biosensor data. ENRGY data and infrastructure can be employed to identify the highest yield sites for prospective studies; identify patients meeting study eligibility criteria; pre‐screen individual patient's willingness to participate in specific studies; centralize study data monitoring; and assist in the conduct of prospective studies.

Conclusion

ENRGY data have been used to generate a growing number of scientific publications and may serve as a model for PBRNs in other specialties seeking to harness the potential of data linkages, patient‐generated data capture, and centralized study infrastructure for observational and interventional research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RheumatologyElectronic Health RecordsHumansUnited StatesProspective StudiesData Warehousing

Autor:innen und Institutionen

  • Foundation for Advancing Science, Technology, Education, and Research (FASTER), Birmingham, Alabama, USA.
  • Illumination Health, Hoover, Alabama, USA.
  • Global Healthy Living Foundation (GHLF), Upper Nyack, New York, USA.
  • University of Pennsylvania School of Medicine, Philadelphia, USA.
  • American Arthritis and Rheumatology Associates (AARA), Boca Raton, USA.
  • University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Timothy Beukelman

Förderung

  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Beukelman, T., Mudano, A., Stewart, P., Venkatachalam, S., Xie, F., George, M., Busch, H., Reddy, P., Saag, K. G., Su, Y., & Curtis, J. R. (2024). Generating Real‐World Evidence From the Excellence Network in Rheumatology. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70067

Vancouver

Beukelman T, Mudano A, Stewart P, Venkatachalam S, Xie F, George M, et al. Generating Real‐World Evidence From the Excellence Network in Rheumatology. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70067

BibTeX
@article{Beukelman2024,
  author = {Beukelman, Timothy and Mudano, Amy and Stewart, Patrick and Venkatachalam, Shilpa and Xie, Fenglong and George, Michael and Busch, Howard and Reddy, Priya and Saag, Kenneth G and Su, Yujie and Curtis, Jeffrey R},
  title = {Generating Real‐World Evidence From the Excellence Network in Rheumatology},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.70067}
}
Kostenlos starten →